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ARE, antioxidant response element; CCK-8, cholecystokinin octapeptide; [Ca
2+
]c, 
intracellular free-Ca
2+
 concentration; EGTA, ethylene glycol-bis(2-aminoethylether)-
N,N,N´N´-tetraacetic acid; ER, endoplasmic reticulum; Fura-2/AM, fura-2 
acetoxymethyl ester; GClc, catalytic subunit of glutamate-cysteine ligase; HO-1, heme 
oxygenase-1; H2O2, hydrogen peroxide; JNK, c-Jun NH(2)-terminal kinase; NCCE, 
non-capacitative Ca
2+
 entry; NQO1; NAD(P)H quinone oxidoreductase 1; Nrf2, nuclear 
factor erythroid 2-related factor; PKC, protein kinase C; PMA, phorbol 12-myristate 13-
acetate. 
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ABSTRACT. 
The goal of this study was to evaluate the potential activation of the nuclear factor 
erythroid 2-related factor and the antioxidant-responsive element (Nrf2–ARE) signaling 
pathway in response to melatonin in isolated mouse pancreatic acinar cells. Changes in 
intracellular free-Ca
2+
 concentration were followed by fluorimetric analysis of fura-2-
loaded cells. The activation of PKC and JNK were measured by western blot analysis. 
Quantitative reverse transcription-polymerase chain reaction was employed to detect the 
expression of Nrf2-regulated antioxidant enzymes. Immunocytochemistry was 
employed to determine nuclear location of phosphorylated-Nrf2, and the cellular redox 
state was monitored following MitoSOX
TM
 Red-derived fluorescence. Our results show 
that stimulation of fura-2-loaded cells with melatonin (1 µM to 1 mM), in the presence 
of Ca
2+
 in the extracellular medium, induced a slow and progressive increase of [Ca
2+
]c 
towards a stable level. Melatonin did not inhibit the typical Ca
2+
 response induced by 
CCK-8 (1 nM). When the cells were challenged with the indoleamine in the absence of 
Ca
2+
 in the extracellular solution (medium containing 0.5 mM EGTA) or in the presence 
of 1 mM LaCl3, to inhibit Ca
2+
 entry, we could not detect any change in [Ca
2+
]c. 
Nevertheless, CCK-8 (1 nM) was able to induce the typical mobilization of Ca
2+
. When 
the cells were incubated with the PKC activator PMA (1 µM) in the presence of Ca
2+
 in 
the extracellular medium, we observed a response similar to that noted when the cells 
were challenged with melatonin 100 µM. However, in the presence of Ro31-8220 (3 
µM), a PKC inhibitor, stimulation of cells with melatonin failed to evoke changes in 
[Ca
2+
]c. Immunoblots, using an antibody specific for phospho-PKC, revealed that 
melatonin induces PKCα activation, either in the presence or in the absence of external 
Ca
2+
. Melatonin induced the phosphorylation and nuclear translocation of the 
transcription factor Nrf2, and evoked a concentration-dependent increase in the 
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expression of the antioxidant enzymes NAD(P)H-quinone oxidoreductase 1, catalytic 
subunit of glutamate-cysteine ligase and heme oxygenase-1. Incubation of MitoSOX
TM
 
Red-loaded pancreatic acinar cells in the presence of 1 nM CCK-8 induced a 
statistically significant increase in dye-derived fluorescence, reflecting an increase in 
oxidation,  that was abolished by pretreatment of cells with melatonin (100 µM) or 
PMA (1 µM). On the contrary, pretreatment with Ro31-8220 (3 µM) blocked the effect 
of melatonin on CCK-8-induced increase in oxidation. Finally, phosphorylation of JNK 
in the presence of CCK-8 or melatonin was also observed. We conclude that melatonin, 
via modulation of PKC and Ca
2+
 signaling, could potentially stimulate Nrf2-mediated 
antioxidant response in mouse pancreatic acinar cells. 
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INTRODUCTION. 
Oxidative stress is a condition of imbalance between reactive oxygen species 
(ROS) formation and antioxidant capacity, as a result of dysfunction of the cellular 
antioxidant system. It has been suggested that excessive amount of ROS could evolve 
towards an oxidative stress condition, and would damage macromolecules like proteins, 
DNA and lipids, finally leading to cell damage [1, 2, 3, 4]. Therefore, oxidative stress 
containment is paramount to protect cell physiology. 
In the pancreas, changes in intracellular free-Ca
2+
 concentration ([Ca
2+
]c) 
represent a crucial signaling mechanism, and the major physiological processes occur 
downstream to Ca
2+
 mobilization [5]. It has been shown that pancreatic damage 
involves Ca²⁺ overload and overproduction of ROS [6]. Ca2+ signals are not only a 
result of Ca
2+
 release from intracellular stores [7], but also involve a coordinate influx 
from the extracellular space [8], Ca
2+
 extrusion across the plasma membrane [9], and 
Ca
2+
 uptake into intracellular organelles [10, 11]. Additionally, the transmission of 
extracellular signals into their intracellular targets is mediated by a network of 
interacting proteins that regulate a large number of cellular processes [12]. 
To counteract oxidative stress, cells have developed endogenous defense 
mechanisms. Among them, the redox sensitive transcription factor nuclear factor 
erythroid 2-related factor (Nrf2) plays a major role in the defense against oxidative 
stress, via the induction of antioxidant enzymes. Under non-stressing conditions, Nrf2 is 
sequestered by its cytosolic binding protein Kelch-like ECH Associated Protein 1 
(Keap1) and targeted for proteasomal degradation. Modification of Keap1 cysteine 
residues leads to nuclear accumulation of Nrf2, where Nrf2 binds to the antioxidant 
response element (ARE). This results in the coordinated transcriptional activation of a 
battery of enzymes and detoxifying proteins, including antioxidant enzymes. Target 
6 
 
genes include NAD(P)H quinone oxidoreductase 1(NQO1), glutamate-cysteine ligase 
(GCL), heme oxygenase-1 (HO-1), glutathione S-transferase (GST) or γ-
glutamylcysteine synthetase (GCS), for example [13, 14]. The mechanism by which 
Nrf2 is stabilized and translocated to the nucleus is under current study. It has been 
proposed that ROS react with specific thiol groups, inducing the dissociation of the 
transcription factor from Keap1 and leading ultimately to Nrf2 nuclear accumulation 
[15]. On the other hand, experimental evidence suggests that Nrf2 phosphorylation may 
release Nrf2 from Keap1 [13].  
Melatonin receptors are widely distributed in the body, and their expression 
differs among various organs [16]. Besides its well-known regulatory role on circadian 
rhythm, melatonin has other biological actions in various cell types and peripheral 
tissues. These actions control detoxification and stress response genes, thus conferring 
protection against a number of xenobiotics and endobiotics produced by acute and 
chronic noxious stimuli [17]. The presence of melatonin MT1 and MT2 type receptors 
in the pancreas has been reported, and evidences indicate that melatonin plays a major 
role in the function of the exocrine pancreas [18, 19]. 
In general, it has been suggested that the indole exerts a regulatory action on 
pancreatic enzyme secretion [20, 21] and on bicarbonate secretion [22]. The indole may 
interact with Ca
2+
 channels and inhibit its influx to inactivate the 5-HT pathway in the 
gut [23]. Melatonin may also modulate Ca
2+
 influx through a non-selective Ca
2+
 
permeable cation channel in transfected CHO cells [24], and can stimulate Ca
2+
 
transport across the cellular membranes [25]. In addition, melatonin exerts antioxidant 
[26, 27] and anti-inflammatory properties on the exocrine pancreas [26, 28-30]. 
Redox-sensitive components are included in the protection mechanisms 
activated by melatonin, which involve transcriptional response dependent on Nrf2. By 
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these pathways, melatonin stimulates the expression of antioxidant and detoxification 
genes [17]. In this line, it has been suggested that melatonin antagonizes oxidative 
injury through the activation of the Keap1-Nrf2-ARE signaling pathway, and can thus 
activate enzymes downstream to Nrf2, therefore reversing oxidative injury in the 
nervous system [31].  This effect has also been suggested in the pancreas, where the 
indoleamine ameliorates cerulein-induced pancreatitis involving the activation of Nrf2 
and NFKB [32]. Recent evidence additionally suggests that the antioxidant action of 
both, melatonin and proteasome inhibitors, involves the Keap1-ARE pathway via the 
up-regulation of Nrf2. Melatonin and proteasome inhibitors suppress the degradation of 
Nrf2 and also enhance its nuclear translocation [33]. Additionally, it has been shown 
that Nrf2-regulated antioxidant response is activated by protein kinase C (PKC) [13, 
34], and that the physiological function of melatonin is coupled to PKC to modulate cell 
physiology in Purkinje neurons [35], in photoreceptors [36], in fibroblasts [37], and in 
myometrial cells [38], for example. 
However, the mechanisms whereby melatonin exerts antioxidant effects in the 
exocrine pancreas are not completely understood. Specially, the involvement of Ca
2+
 
signaling in melatonin-evoked effects needs deep attention, because most cellular 
activity in the pancreas is initiated by changes in [Ca
2+
]c. In the present study, we aimed 
to investigate the mechanisms by which melatonin protects the exocrine pancreas 
against oxidative stress, paying attention to Nrf2 activation and the involvement of Ca
2+
 
homeostasis. 
 
MATERIALS AND METHODS. 
Animals and chemicals. 
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Adult male Swiss mice, weighing between 25 and 30 g, were used in the present 
study. Animals were obtained from the animal house of the University of Extremadura 
(Caceres, Spain). Animals were humanely handled and sacrificed in accordance to the 
institutional Bioethical Committee. Collagenase CLSPA was obtained from 
Worthington Biochemical Corporation (Lakewood, NJ, U.S.A.). Cell Lysis Reagent for 
cell lysis and protein solubilization, (Tyr[SO3H]
27
) cholecystokinin fragment 26–33 
amide (CCK-8), ethylene glycol-bis(2-aminoethylether)-N,N,N´N´-tetraacetic acid 
(EGTA), melatonin, Tween
®
-20, propidium iodide, phorbol 12-myristate 13-acetate 
(PMA), protease inhibitor cocktail (Complete, EDTA-free) and thapsigargin were 
obtained from Sigma Chemicals Co. (Madrid, Spain). Fura-2-AM, hydrogen peroxide 
(H2O2) and MitoSOX
TM
 Red were obtained from Life Technologies (Invitrogen, 
Barcelona, Spain). Bradford reagent, Tris/glycine/SDS buffer (10×) and Tris/glycine 
buffer (10×) were from Bio-Rad (Madrid, Spain). Enhanced chemiluminescence 
detection reagents were obtained from Pierce (Fisher Scientific Inc., Madrid, Spain). 
Antibodies against phospho-PKCα and α-tubulin were purchased from Santa Cruz 
Biotechnology Inc. (Quimigranel S.A., Madrid, Spain). Anti phospho-Nrf2 antibody 
was obtained from Bioss (Interchim, Montlucon, France). Antibody against phospho-
SAPK/JNK (Thr183/Tyr185) was purchased from Cell Signaling (IZASA Biolabs, S.A., 
Barcelona, Spain). Secondary antibodies rabbit anti-goat IgG-HRP, goat anti-rabbit 
IgG-HRP and goat anti-rabbit IgG FITC-conjugate antibody were purchased from 
Pierce (Fisher Scientific Inc., Madrid, Spain). All other analytical grade chemicals used 
were obtained from Sigma Chemicals Co. (Madrid, Spain). 
 
Preparation of isolated pancreatic acinar cells. 
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A suspension of mouse pancreatic single cells and small acini was prepared as 
described previously [10]. Briefly, after mice had been killed by severing of the 
vertebral column, the pancreas was removed rapidly and placed in a physiological Na-
HEPES solution (composition -in mM-: NaCl 130; KCl 4.7; CaCl2 1.3; MgCl2 1; 
KH2PO4 1.2; glucose 10; HEPES 10) containing 0.01% trypsin inhibitor (soybean) and 
0.2% bovine serum albumin (BSA) and pH adjusted to 7.4 with NaOH. This buffer was 
supplemented with 30 units/mL collagenase CLSPA from Worthington. Tissues were 
incubated for 10 min at 37 ºC, after which the cell suspension was gently pipetted 
through tips of decreasing diameter for mechanical dissociation of the cells. After 
centrifugation at 30 × g for 5 min at 4 ºC, cells were resuspended in Na-HEPES buffer 
without collagenase. Cell viability was not significantly changed by the isolation 
procedure, as assayed by trypan blue exclusion test, and was greater than 95%. 
 
Fura-2 loading and determination of dye-derived fluorescence. 
Freshly isolated mouse pancreatic acinar cells, resuspended in Na-HEPES 
buffer, were loaded with fura-2-AM (4 µM) at room temperature (23–25 ºC) for 40 min, 
as described previously [39]. Then, cells were centrifuged at 30 × g for 5 min at 4 ºC 
and resuspended in Na-HEPES buffer without trypsin inhibitor and BSA.  
For monitorization of changes of fura-2-dependent fluorescence, related to changes in 
[Ca
2+
]c, small aliquots of dye-loaded cells were transferred to a coverslip mounted on an 
experimental perfusion chamber, and placed on the stage of an epifluorescence inverted 
microscope (Nikon Diaphot T200, Melville, NY, USA). 
The cells were continuously superfused with a control Na-HEPES buffer containing (in 
mM): 140 NaCl, 4.7 KCl, 1 CaCl2, 2 MgCl2, 10 Hepes, 10 glucose (pH adjusted to 7.4). 
When Ca
2+
 free conditions were applied, the Na-HEPES buffer contained no added Ca
2+
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and was supplemented with 0.5 mM EGTA. In order to determine fura-2-derived 
fluorescence, an image acquisition system was employed (Hamamatsu Photonics, 
Hamamatsu, Japan). Cells were excited alternatively at 340/380 nm, with light from a 
xenon arc lamp passed through a high-speed monochromator (Polychrome IV, 
Photonics, Hamamatsu, Japan). Fluorescence emission at 505 nm was detected using a 
cooled digital CCD camera (Hisca CCD C-6790, Hamamatsu, Japan) and recorded 
using dedicated software (Aquacosmos 2.5, Hamamatsu Photonics, Hamamatsu, Japan). 
The ratio of fura-2-emitted fluorescence closely reflects changes in [Ca
2+
]c [40]. 
In this series of experiments, results are expressed in units of fluorescence (u. f.) as the 
ratio of fluorescence emitted at 340 nm and 380 nm excitation wavelengths, normalized 
to the basal fluorescence. All fluorescence measurements were made from areas 
considered individual cells. 
Cell viability was not changed by the isolation procedure, as determined using 
the trypan blue exclusion test, and was > 95%. After loading with the fluorescent dye, 
cells were kept at 4 ºC until use, and experiments were performed within 4 h. In 
experiments in which Ca
2+
-free medium was used, Ca
2+
 was omitted and 0.5 mM 
EGTA was added to the extracellular solution. In the experiments in which the effect of 
La
3+
 was tested, neither Ca
2+
 nor EGTA were added to the extracellular solution. No 
apparent morphological changes of cells were observed that could yield errors in Ca
2+
 
measurements. 
All stimuli were dissolved in the extracellular Na-HEPES buffer, with or without 
Ca
2+
, and applied directly to the cells in the perfusion chamber. Experiments were 
performed at room temperature (23–25 ºC), and different batches of cells were used for 
the studies. 
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Western blot analysis. 
For western blotting analysis cells were incubated with the appropriate stimulus, 
centrifuged and then washed twice with PBS. After washing, cells were sonicated for 5 
s at 4 ºC in 100 µL of lysis buffer, supplemented with protease inhibitor cocktail and 0.2 
mM Na3VO4. The homogenates were clarified by centrifugation at 10000 × g (15 min, 4 
°C) and the supernatant was used for analysis of protein concentration followed by 
dilution with 4× SDS sample buffer. Protein lysates (30 µg/well) were fractionated by 
SDS-PAGE using 10% polyacrylamide gels and transferred to nitrocellulose 
membranes. After blocking, membranes were incubated overnight at 4 ºC with the 
specific primary antibody. The following day, membranes were washed twice and 
incubated for 45 min at 25 °C with IgG-HRP conjugated secondary antibody. 
Membranes were then washed again, incubated with enhanced chemiluminescence 
detection reagents, and, finally, exposed to Hyperfilm ECL films (Amersham, Arlington 
Heights, IL). The intensity and molecular weight of the bands which appear were 
quantified using the software Image J (http://imagej.nih.gov/ij/). The experiments were 
carried out employing different batches of cells, prepared on different days. 
 
Quantitative reverse transcription-polymerase chain reaction (RT-qPCR) 
analysis. 
This was performed in total RNA samples, purified from isolated mouse 
pancreatic cells using a commercially available kit (Sigma, Madrid, Spain), utilizing the 
Power SYBR Green RNA-to-CT
TM
 1-Step kit (Applied Biosystems, Township, USA). 
Reverse transcription was performed for 30 min at 48 ºC, and PCR conditions were 10 
min at 95 ºC followed by 40 cycles of 15 s at 95 ºC plus 1 min at 55 ºC using the 
following forward and reserve primers, respectively (Thermo Scientific, Offenbach, 
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Germany), 5´ -AGCACAGGGTGACAGAAGAG-3´ and 5´ -
GAGGGACTCTGGTCTTTGTG-3´ (Gclc), 5´ -GGCACAAGGACGTGCTCAAGT-3´ 
and 5´ -TGCAGAGTTTCAAGAACATCG-3´ (Ho-1), 5´ -
GGGGACATGAACGTCATTCTCT-3´ and 5´ -AAGACCTGGAAGCCACAGAAGC-
3´ (Nqo-1), 5´ -GGGTGTGAACCACGAGAAAT-3´ and 5´ -
CCTTCCACGATGCCAAAGTT-3´ (Gapdh). The mRNA abundance of each transcript 
was normalized to the Gapdh mRNA abundance obtained in the same sample. The 
relative mRNA levels were calculated using the ΔΔCt method, and were expressed as 
the fold change between sample and calibrator. 
 
Immunocytochemistry. 
This procedure was employed to determine phosphorylated-Nrf2 location. 
Briefly, the cells were fixed with 4% paraformaldehyde, permeabilized with 0.1% 
Triton X-100 and incubated with the specific primary antibody. After washing out the 
first antibody, cells were incubated with a FITC-labeled secondary antibody. 
Monitorization of FITC-derived fluorescence signals was performed employing 
confocal laser-scanning microscopy (Bio-Rad, MRC 1024; American Laser Corp., Salt 
Lake City, UT). Using a × 60 oil immersion objective fluorescence, images of 256 × 
256 pixels with a resolution of 0.287 mm/pixel were recorded. Samples were excited at 
488 nm from a 100 mW argon ion laser and emitted fluorescence was collected through 
a 522/35-nm band-pass filter employing a photomultiplier. Propidium iodide was 
excited with the 543-nm line from a 25-mW helium–neon laser, and emission was 
collected through a 605/32-nm band-pass filter. The software used for the imaging was 
Laser Sharp MRC-1024 Version 3.2 (Bio-Rad, Deisenhofen, Germany). The absence of 
non-specific staining was assessed by processing the samples without primary antibody. 
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Determination of oxidation. 
For the determination of the redox state, cells were incubated in the presence of 
MitoSOX
TM
 Red (2.5 mM) for 15 min. at 37 ºC. Generation of ROS was determined by 
measuring cellular fluorescence at 510 nm/580 nm (excitation/emission) using an 
ELISA spectrofluorimeter (Tecan Infinite M200, Grödig, Austria). Data show the mean 
increase of fluorescence expressed in percentage ± S.E.M. (n) with respect to control 
(non-stimulated) cells, where n is the number of independent experiments. 
 
Statistical analysis. 
Statistical analysis of data was performed by one-way analysis of variance 
(ANOVA) followed by Tukey post hoc test, and only P values < 0.05 were considered 
statistically significant. For individual comparisons and statistics between individual 
treatments we employed Student’s t test, and only P values < 0.05 were considered 
statistically significant. 
 
RESULTS. 
Changes in [Ca
2+
]c in response to melatonin. 
Stimulation of fura-2-loaded cells with 1 nM CCK-8, in the presence of 
extracellular Ca
2+
 (1 mM), induced an initial increase in [Ca
2+
]c that was followed by a 
decrease towards a plateau value over the prestimulation level (n = 4 experiments/97 of 
97 total cells studied; Fig. 3A, continuous line). When the cells were incubated with 
CCK-8 (1 nM) in the absence of extracellular Ca
2+
 (medium containing 0.5 mM EGTA) 
a similar response was observed; however, the recovery of [Ca
2+
]c was faster and 
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decreased towards the prestimutation level (n = 3 experiments/60 of 60 total cells 
studied; Fig. 1A, dashed line). 
In the next set of experiments the cells were incubated with different 
concentrations of melatonin (1 µM to 1 mM), in the presence of Ca
2+
 in the extracellular 
medium (Fig. 1B-E). The pattern of Ca
2+
 mobilization that we observed consisted of a 
slow and progressive increase of [Ca
2+
]c towards a stable level. In occasions, single and 
short amplitude spikes in [Ca
2+
]c could be noted. At the end of each experiment cells 
were stimulated with 1 nM CCK-8, and we obtained the typical Ca
2+
 response induced 
by the agonist. Throughout the following determinations, we chose the concentration of 
100 µM melatonin, a concentration that has shown clear effects in recent studies [21, 
41]. 
To find out the source of the increase in [Ca
2+
]c that we observed when the cells 
were incubated with melatonin, cells were challenged with the indoleamine in the 
absence of Ca
2+
 in the extracellular solution (medium containing 0.5 mM EGTA). 
Under these conditions we could not detect any change in [Ca
2+
]c when the cells were 
challenged with melatonin. At the end of the experiment, cells were stimulated with 1 
nM CCK-8, which evoked a typical mobilization of Ca
2+
 (Fig. 2A). These observations 
suggest that the responses of [Ca
2+
]c noted in the presence of melatonin could have an 
extracellular origin. 
To further study the extracellular origin of the responses evoked in [Ca
2+
]c by 
melatonin, cells were incubated in the presence of 1 mM LaCl3. It has been shown that 
LaCl3 blocks the entry of Ca
2+
 through the plasma membrane [42, 43]. Now, any 
increase of [Ca
2+
]c would be a consequence of its release from intracellular stores. Thus, 
the cells were incubated with melatonin (100 µM) and in the presence of 1 mM LaCl3 in 
the extracellular solution (Fig. 2B). We could not observe any change in [Ca
2+
]c when 
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the cells were challenged with melatonin. At the end of the experiment, cells were 
stimulated with 1 nM CCK-8, which evoked a typical mobilization of Ca
2+
. These 
observations support the hypothesis that the responses of [Ca
2+
]c noted in the presence 
of melatonin have an extracellular origin. 
 
Involvement of PKC in melatonin-evoked changes in [Ca
2+
]c. 
Stimulation of PKC has been related to the activation of Ca
2+
 entry [44, 45]. 
Therefore, we investigated whether activation of PKC was related to the Ca
2+
 entry that 
we observed in the presence of melatonin. For this purpose, fura-2-loaded cells were 
challenged with 1 µM PMA, a PKC activator [44], in the presence of Ca
2+
 in the 
extracellular medium (Fig. 3A; n = 5 experiments/100 of 100 total cells studied). Under 
these conditions, we observed a slow and progressive increase of [Ca
2+
]c towards a 
stable level, similar to that noted when the cells were challenged with melatonin. When 
the indoleamine was included in the extracellular solution we could not observe further 
increases in [Ca
2+
]c. At the end of the experiment, stimulation of cells with 1 nM CCK-8 
evoked the typical Ca
2+
 response induced by the agonist. 
In another set of experiments, cells were incubated in the presence of the PKC 
inhibitor Ro31-8220 [46]. In the presence of the PKC inhibitor (3 µM), stimulation of 
cells with melatonin (100 µM) failed to evoke a change in [Ca
2+
]c. Again, stimulation of 
cells with 1 nM CCK-8 at the end of the experiment evoked a typical Ca
2+
 response 
(Fig. 3B; n = 6 experiments/127 of 138 total cells studied). These results suggest that 
melatonin induces Ca
2+
 entry from the extracellular medium via PKC activation. 
Members of the PKC family play a key regulatory role in a variety of cellular 
functions, including cell growth and differentiation, gene expression, hormone secretion 
and membrane function. PKC isoforms can be activated through phosphorylation. 
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Confirmation of PKC activation by melatonin was carried out by western blot. 
Immunoblots using an antibody specific for phospho-PKCα were performed. Pancreatic 
acinar cells were incubated with 1 µM - 100 µM melatonin for 1 hour, in the presence 
of Ca
2+
 in the extracellular medium.  Then, cell lysates were analyzed to determine the 
level of PKCα phosphorylation. The data indicate that incubation of pancreatic acinar 
cells with melatonin resulted in a concentration-dependent increase in the level of 
phosphorylated PKCα. PMA (1 µM) also evoked a significant increase in the 
phosphorylation of the kinase (Fig. 4A and B). 
To ascertain whether Ca
2+
 entry was necessary for melatonin-induced 
phosphorylation of PKCα, cells were challenged with melanonin (1 µM – 100 µM) or 
PMA (1 µM) in the absence of Ca
2+
 in the extracellular medium. Under these 
conditions, incubation of cells with the stimuli also induced phosphorylation of PKCα 
(Fig. 4A and C). The results show that melatonin induces phosphorylation of the kinase 
either in the presence or in the absence of Ca
2+
 in the extracellular medium. 
 
Activation by melatonin of crucial Nrf2-dependent antioxidant enzymes. 
Nrf2 is a transcription factor that functions as the key controller of the redox 
homeostatic gene regulatory network. Upon activation, the Nrf2 signaling enhances the 
expression of a multitude of antioxidant and phase II enzymes that restore redox 
homeostasis [14]. To study whether melatonin could stimulate the transcriptional 
activation of certain antioxidant enzymes through the activation of Nrf2, RT-qPCR of 
the relative mRNA abundance was performed. Results reveal that melatonin (1 hour 
incubation; 1 µM - 100 µM) evoked a concentration-dependent and statistically 
significant increase in the expression of GCLc, HO-1 and NQO1 (Fig. 5). However, we 
could not detect any significant increase in the expression of the mentioned antioxidant 
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enzymes when the cells were incubated during 1 hour in the presence of the pancreatic 
secretagogue CCK-8 (1 nM). To evaluate the implication of PKC in the actions of 
melatonin, cells were incubated for 1 hour in the presence of 1 µM PMA. The PKC 
activator induced a statistically significant increase in the expression of the mentioned 
antioxidant enzymes (Fig. 5). On the contrary, inhibition of PKC by preincubation of 
cells during 1 hour with Ro31-8220 (3 µM) inhibited the effect of melatonin (100 µM; 
Fig. 5). Moreover, to ascertain if the Ca
2+
 influx activated by melatonin contributed to 
the activation of the Nrf2-dependent antioxidant enzymes, we carried out the 
experiments in the absence of extracellular Ca
2+
 (we employed a nominally Ca
2+
 free 
medium, i.e., no Ca
2+
 was added to the extracellular solution, that was prepared 
employing milli-Q water). Under these conditions, melatonin (100 µM) failed to induce 
any increase in the expression of the mentioned antioxidant enzymes (Fig. 5). As a 
control, cells were incubated in the presence of H2O2 (100 µM), a known Nrf2 activator 
[47]. The oxidant triggered the expression of all three antioxidant enzymes studied (Fig. 
5). 
Having determined that melatonin induced changes in the expression of 
antioxidant enzymes regulated by Nrf2, it was of interest to analyze whether melatonin 
influences the phosphorylation and nuclear translocation of the transcription factor. For 
this purpose we performed immunocytochemical studies, employing a specific antibody 
against the phosphorylated form of Nrf2. In non-treated cells, we did not observe 
nuclear staining for the transcription factor (Fig. 6A). In the presence of the indoleamine 
(100 µM; 1 hour incubation), phosphorilated Nrf2 could be detected in the nucleus (Fig. 
6B). A similar effect was observed when the cells were incubated with PMA (1 µM; 
Fig. 6C). However, we could not observe nuclear translocation of Nrf2 when the cells 
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were stimulated with melatonin in the absence of extracellular Ca
2+
 (Fig. 6D) or after 
previous inhibiton of PKC by incubation of cells with Ro31-8220 (3 µM) (Fig. 6E). 
These results provide evidences that melatonin induces the nuclear translocation 
of the transcription factor Nrf2, and stimulates the expression of crucial antioxidants 
enzymes that might regulate the cellular redox status. 
 
Effect of melatonin on the oxidative state of pancreatic acinar cells.  
Bearing in mind that melatonin stimulated Nrf2-dependent antioxidant enzymes 
expression, we investigated the effect of the indoleamine on the cellular oxidative state. 
For this purpose we employed the redox-sensitive fluorescent dye MitoSOX
TM
 Red, and 
we studied the protective effect of melatonin against CCK-8-evoked oxidation. This is a 
pancreatic agonist that induces oxidation in the exocrine pancreas [38]. Incubation 
during 1 hour of MitoSOX
TM
 Red-loaded pancreatic acinar cells in the presence of 1 
nM CCK-8 induced a statistically significant increase in dye-derived fluorescence, 
suggesting oxidation of the dye (Fig. 7). Melatonin (100 µM; 1 hour incubation) did not 
increase MitoSOX
TM
 Red -derived fluorescence compared with that observed in control 
(non-stimulated) cells (Fig. 7). When the cells were preincubated with melatonin (100 
µM; 5 min. preincubation) and then were stimulated with CCK-8 (1 nM), the oxidation 
induced by CCK-8 was blunted. A similar effect was observed when the cells were 
preincubated in the presence of the PKC activator PMA (1 µM). On the contrary, 
inclusion of the PKC inhibitor Ro31-8220 (3 µM) blocked the protective effect of 
melatonin on CCK-8-induced increase in MitoSOX
TM
 Red fluorescence (Fig. 7). As a 
control, we tested the effect of H2O2, a well known oxidant. In the presence of H2O2 
(100 μM) an increase in MitoSOXTM Red -derived fluorescence was observed (Fig. 7). 
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These data suggest that activation of PKC by melatonin is involved in the 
protective effect of the indoleamine against CCK-8-induced oxidation in mouse 
pancreatic acinar cells. The results further support a putative relationship between the 
effects of melatonin on Nrf2 and the activation of cellular antioxidant response. 
 
Effect of melatonin on JNK. 
In the exocrine pancreas, agonists can activate several signaling pathways which 
may directly or indirectly influence ROS formation. In a former work, performed in a 
cellular model of pancreatitis, it has been shown that cerulein induced ROS formation 
involving c-Jun NH(2)-terminal kinase (JNK) activation [49]. 
To analyze whether JNK is involved in melatonin-evoked responses in 
pancreatic acinar cells, we carried out immunoblots using an antibody specific for 
phospho-SAPK/JNK. Pancreatic acinar cells were incubated for 1 hour with 100 µM 
melatonin, 1 nM CCK-8 or 1 µM PMA, in the presence of Ca
2+
 in the extracellular 
medium. Then cell lysates were analyzed to determine the level of SAPK/JNK 
phosphorylation. The data indicate that incubation of pancreatic acinar cells with 
melatonin resulted in an increase in the level of phosphorylated SAPK/JNK. CCK-8 (1 
nM) and PMA (1 µM) also evoked significant increases in the phosphorylation of the 
kinase (Fig. 8). 
 
DISCUSSION. 
Melatonin is produced in the mammalian pineal gland and retina following a 
circadian rhythm with high levels being released from the pineal in the blood at night, 
and regulates an array of physiological processes [19, 50, 51]. Melatonin is also 
released from the gastrointestinal tract, where the amount of this indole is greater than 
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the content of melatonin in the central nervous system [52]. Moreover, the indole is 
present in plant foods [53].  
Melatonin MT1 and MT2 receptors are widely expressed throughout the body 
(gastrointestinal tract included) [54], and it exhibits antioxidant and anti-inflammatory 
functions. Actually, active research is carried out in order to clarify the signaling 
pathway activated by melatonin in the induction of antioxidant response. Existing data 
support that the actions of the indoleamine are related to its effects on intracellular 
cAMP [55], reactive oxygen species (ROS) production [56], via the cGMP signaling 
pathway [57], or involving Ca
2+
 signaling [18, 21, 58, 59]. Recently, it has been 
suggested that melatonin protects the pancreatic damage via the decrease of oxidative 
stress and an increase of the activities of antioxidant enzymes [60]. In the latter work, 
the total antioxidant status and glutathione peroxidase activity were determined in vivo. 
However, the intracellular mechanisms involved in melatonin-evoked antioxidant 
responses in the exocrine pancreas remain to be elucidated. Our work has evaluated the 
probable mechanisms by which melatonin sets on the antioxidant response and protects 
the exocrine pancreas against oxidative stress. 
Ca
2+
 is a second messenger involved in the regulation of pancreatic exocrine 
function [5]. Therefore, investigation of the effects of melatonin on [Ca
2+
]c would 
provide important information on the role of melatonin in the regulation of pancreatic 
acinar cells physiology. Our results suggest that the indole is stimulating the entry of 
Ca
2+
 from the extracellular space. Melatonin-evoked Ca
2+
 signals were not detected if 
extracellular Ca
2+
 was omitted, and also in the presence of La
3+
. This effect resembles 
the characteristics of a non-capacitative Ca
2+
 entry (NCCE). The movement of Ca
2+
 into 
the cell via this pathway has been previously described [61, 62]. Moreover, Ca
2+
 influx 
evoked by the indoleamine involved PKC activation. Indeed, melatonin induced 
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phosphorylation of the kinase either in the presence or in the absence of Ca
2+
 in the 
extracellular medium. Thus, our results suggest that PKC is activated by melatonin, and 
afterwards Ca
2+
 entry takes place. This is consistent with our observations, in which we 
could not detect Ca
2+
 entry in cells stimulated with melatonin in the presence of the 
PKC inhibitor Ro31-8220. Our results support previous findings that report the 
involvement of PKC in melatonin-induced Ca
2+
 signals [63], and in the activation of 
NCCE [64]. 
Cellular redox homeostasis mediates a plethora of cellular pathways that 
determine life and death events. The balance between oxidative stress and protective 
mechanisms predisposes the daily evolution of cellular physiology. Imbalances between 
them can produce aberrant redox homeostasis with resultant pathologies. It has been 
proposed that melatonin upregulates the expression of antioxidant enzymes. Recent 
evidence suggests that the antioxidant action of melatonin involves the Keap1-ARE 
pathway via the upregulation of Nrf2 [65]. The action of melatonin on Nrf2 pathway 
has been shown in several tissues. For example, melatonin markedly promoted the 
translocation of Nrf2 protein from the cytoplasm to the nucleus, increased the 
expression of Nrf2-ARE pathway-related downstream factors, and prevented the decline 
of antioxidant enzyme activities, attenuating brain injury [66]. Melatonin enhanced the 
expression of HO1 via NF-κB, p38 MAPK and Nrf2 cascade signaling pathways in 
murine peritoneal macrophages [67]. Additionally, melatonin treatment increased Nrf2 
accumulation in the nuclear fraction, and increased the expression of HO-1 in the 
cytosolic fraction, attenuating cisplatin-induced nephrotoxicity [68], or protecting 
endothelial cells [69] and liver [70] against ischemic injury. 
In view of our previously published results, which show that melatonin does not 
stimulate amylase release in pancreatic acinar cells [20], we might speculate that the 
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route for Ca
2+
 entry activated by melatonin might selectively direct Ca
2+
 to processes 
that mediate activation of the ARE in pancreatic acinar cells. 
Our results support this hypothesis. Here we have shown that incubation of 
pancreatic acinar cells with melatonin induced nuclear translocation of phosphorylated 
Nrf2. Moreover, in the presence of melatonin, we detected an increase in the expression 
of the Nrf2-regulated antioxidant enzymes NQO1, GCLc and HO-1. Interestingly, 
extracellular Ca
2+
 and PKC activation were involved in the expression of such enzymes. 
Finally, melatonin protected pancreatic acinar cells against CCK-8-induced oxidation, 
and PKC was involved in this effect. 
Sledzinski et al. [49] suggested that CCK-8 can activate several signaling 
pathways which directly or indirectly may influence ROS formation. The authors 
showed that activation of JNK was involved in an iron-dependent ROS formation. We 
could speculate with a putative effect of melatonin on JNK-phsophorylation state to 
modulate ROS formation in pancreatic acinar cells. Taking into account the mentioned 
work, a decrease in ROS formation would be explained by an inhibition of JNK in the 
presence of melatonin. However, we have observed an increase in the phosphorylation 
of JNK in the presence of melatonin, despite we did not detect any increase in ROS 
formation in cells incubated with the indole. We also observed an increase in 
phosphorylated JNK when the cells were challenged with CCK-8 or PMA. However, 
we noted a decrease in ROS formation when the cells were incubated with melatonin or 
PMA plus CCK-8 compared with the effect of CCK-8 alone. Our results rather suggest 
that the effect of melatonin on the cellular redox status seems not to involve inactivation 
of JNK. Therefore, changes in antioxidant enzyme genes expression might be of major 
relevance in the actions of melatonin to modulate redox status in our cellular model. 
23 
 
In conclusion, our observations suggest that melatonin potentially stimulates 
Nrf2-mediated antioxidant enzyme expression in mouse pancreatic acinar cells. The 
mechanisms that underlie such action seem to involve the activation of PKC and Ca
2+
 
entry from the extracellular space. This is of the greatest significance, because induction 
of antioxidant enzyme synthesis through Nrf2 is a fundamental process in cellular 
response to stress, letting the cell compensate for the damages caused by oxidants. 
Thus, targeting the Nrf2 defense pathway by melatonin may represent a mechanism by 
which the indoleamine might prevent oxidative stress-induced damage in the exocrine 
pancreas. The mechanisms by which melatonin is coupled to PKC deserves future 
study. 
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Legends to figures. 
 
Figure 1. Changes in [Ca
2+
]c in response to cholecystokinin (CCK)-8 and melatonin 
(1 µM – 1 mM). (A) Time-course of changes in [Ca2+]c in fura-2-loaded mouse 
pancreatic acinar cells stimulated with 1 nM CCK-8 alone in the presence (continuous 
line; n = 4 expt./97 of 97 total cells studied) or in the absence of Ca
2+
 in the extracellular 
medium (dashed line; n = 3 expt./60 of 60 total cells studied; e.c., extracellular Ca
2+
). 
(B-E) Cells were incubated in the presence of 1 µM (n = 8 expt./66 of 128 total cells 
studied), 10 µM (n = 9 expt; 90 of 146 total cells studied), 100 µM (n = 21 expt; 325 of 
485 total cells studied), or 1 mM (n = 8 expt./48 of 110 total cells studied) melatonin. In 
the presence of melatonin, cells were further stimulated with 1 nM CCK-8. The 
horizontal continuous bars indicate the time during which stimuli were applied to the 
cells. A thin dashed horizontal line indicates the level corresponding to basal [Ca
2+
]c. 
 
Figure 2. Changes in [Ca
2+
]c in response to melatonin (100 µM) in the absence of 
an extracellular source for Ca
2+
 influx. (A) Time-course of changes in [Ca
2+
]c in fura-
2-loaded mouse pancreatic acinar cells incubated with 100 µM melatonin in the absence 
of extracellular Ca
2+
 (e.c.; medium containing 0.5 mM EGTA) (n = 20 expt./397 of 504 
total cells studied). As a control, and in the presence of melatonin, cells were further 
stimulated with 1 nM CCK-8. (B) Cells were incubated in the presence of 1 mM LaCl3 
and then were stimulated with 100 µM melatonin. At the end of the experiment cells 
were stimulated with 1 nM CCK-8. The experiments were carried out in a medium 
nominally free of Ca
2+
, i.e., no Ca
2+
 was added and EGTA was omitted in order to avoid 
competition with La
3+
  (n = 7 expt./136 of 156 total cells studied). The horizontal 
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continuous bars indicate the time during which stimuli were applied to the cells. A thin 
dashed horizontal line indicates the level corresponding to basal [Ca
2+
]c. 
 
Figure 3. Involvement of PKC activation in melatonin-evoked changes in [Ca
2+
]c. 
(A) Time-course of changes in [Ca
2+
]c in fura-2-loaded mouse pancreatic acinar cells 
incubated with 1 µM PMA in the presence of extracellular Ca
2+
. Following 
preincubation of cells with the PKC activator, melatonin (100 µM) was included in the 
extracellular solution. At the end of the experiment, cells were further stimulated with 1 
nM CCK-8 (n = 5 experiments/100 of 100 total cells studied). (B) Cells were incubated 
in the presence of the PKC inhibitor Ro31-8220 (3 µM) and then were stimulated with 
100 µM melatonin. At the end of the experiment cells were stimulated with 1 nM CCK-
8 (n = 6 expt./127 of 138 total cells studied). The horizontal continuous bars indicate the 
time during which stimuli were applied to the cells. A thin dashed horizontal line 
indicates the level corresponding to basal [Ca
2+
]c. 
 
Figure 4. Activation of PKC by melatonin. (A) Representative blots showing the 
phosphorylation status of PKCα evaluated with a phosphospecific antibody, in the 
presence or in the absence of Ca
2+
 in the extracellular medium. To ensure equal loading 
of proteins, the levels of α-tubulin were employed as controls under the tested 
conditions. Cells were incubated during 1 hour with the appropriate stimulus, in the 
presence or in the absence of extracellular Ca
2+
. The experiment shown is representative 
of three others. (B and C) The graphs show the quantification of protein 
phosphorylation. Values are the mean ± S.E.M. of normalized values expressed as % of 
phosphorylation in non-stimulated cells (*, P < 0.05; **, P < 0.01; and ***, P < 0.001 
vs non-stimulated cells). 
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Figure 5. Quantitative real-time PCR (RT-qPCR) analysis of the relative mRNA 
abundance of Nrf2-dependent antioxidant enzymes in mouse pancreatic acinar 
cells. RT-qPCR analysis of Nrf2-target genes: glutamate cysteine ligase-catalytic 
subunit (GClc; A), heme-oxygenase-1 (HO-1; B) and (NQO1; C), reveals statistically 
significant increases in the levels of Nrf2-dependent antioxidant enzymes in cells 
incubated during 1 hour in the presence of melatonin. When the cells were challenged in 
the presence of CCK-8 (1 nM; 1 hour incubation), no statistically significant changes in 
the expression of the antioxidant enzymes could be noted. Incubation of cells for 1 hour 
with the PKC activator PMA (1 µM) also evoked an increase in the expression of all 
three antioxidant enzymes. Preincubation of cells during 1 hour in the presence of the 
PKC inhibitor Ro31-8220 (3 µM) or in the absence of extracellular Ca
2+
 blunted the 
effect of melatonin (the concentration of indoleamine employed was 100 µM). Gapdh 
mRNA was used for normalization. Data are expressed as the mean ± S.E.M. of the 
change relative to non-treated cells (n = 3 independent experiments; *, p < 0.05). 
 
Figure 6. Immunocytochemistry study of cells showing intracellular localization of 
phosphorylated-Nrf2. (A) Nuclear translocation of phosphorylated-Nrf2 could not be 
detected in non-treated cells. (B) Cells were incubated for 1 hour in the presence of 100 
µM melatonin. (C) Treatment of cells during 1 hour with the PKC activator PMA (1 
µM) induced a similar effect to that noted with melatonin. (D) Preincubation of cells in 
the absence of extracellular Ca
2+
 (nominally free Ca
2+
 medium) blocked the effect of 
melatonin. (E) We could not detect nuclear staining for phosphorylated-Nrf2 if cells 
were preincubated for 1 hour in the presence of the PKC inhibitor Ro31-8220 (3 µM), 
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prior to the treatment of cells with melatonin. Images are representative of three 
different preparations (N, nucleus). 
 
Figure 7. Study of the oxidative state of pancreatic acinar cells loaded with the 
redox-sensitive dye MitoSOX
TM
 Red. Cells were incubated during 1 hour in the 
presence of different stimuli, and the effect on MitoSOX
TM
 Red oxidation was studied. 
Results report the oxidative state of treated cells compared with that of control (non-
treated) cells. Data are representative of six independent experiments (**, P < 0.01; and 
***, P < 0.001 vs non-treated cells. †, P < 0.05; ††, P < 0.01; †††, P < 0.001  vs CCK-
8). 
 
Figure 8. Effect of melatonin on JNK. (A) Representative blots showing the 
phosphorylation status of JNK evaluated with a phosphospecific antibody. To ensure 
equal loading of proteins, the levels of α-tubulin were employed as controls under the 
tested conditions. Cells were incubated during 1 hour in the presence of the appropriate 
stimulus. The experiment shown is representative of three others. (B) The graphs show 
the quantification of protein phosphorylation. Values are the mean ± S.E.M. of 
normalized values expressed as % of phosphorylation in non-stimulated cells (*, P < 
0.05 vs non-stimulated cells).  
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Melatonin induces PKCα activation in mouse pancreatic acinar cells 
 
Non-capacitative Ca2+ influx is observed in the presence of melatonin 
 
Melatonin induces nuclear translocation of Nrf2 
 
Melatonin induces the expression of antioxidant enzymes 
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